Paroxetine can improve primary visual cortex activity in a high-risk mouse model of schizophrenia
Visual cortex functional deficits can be observed in schizophrenia patients and in individuals at high risk of schizophrenia. However, to date, few studies have investigated methods to improve these functional deficits. This study aimed to investigate the pathological change in the primary visual co...
Main Authors: | Xinying Chen, Ziyao Cai, Feng Ji, Xiaodong Lin, Deguo Jiang, Chongguang Lin, Xiaoyan Ma, Yong Xu, Wenqiang Wang, Lidan Zheng, Ce Chen, Chuanjun Zhuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Biotechnology & Biotechnological Equipment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13102818.2020.1837009 |
Similar Items
-
Paroxetine in the Treatment of Post Traumatic Stress Disorder: Our Experiences
by: Abdulah Kučukalić, et al.
Published: (2008-02-01) -
Effects of personality on the association between paroxetine plasma concentration and response
by: Tomita T, et al.
Published: (2018-11-01) -
Paroxetine prevented the down-regulation of astrocytic L-Glu transporters in neuroinflammation
by: Koki Fujimori, et al.
Published: (2015-01-01) -
Paroxetine—Overview of the Molecular Mechanisms of Action
by: Magdalena Kowalska, et al.
Published: (2021-02-01) -
Efficacy of ziprasidone and risperidone in treatment of vagrants with schizophrenia
by: Zhan-Hua Li, et al.
Published: (2016-06-01)